354PDCOST EFFECTIVENESS ANALYSIS OF EVEROLIMUS PLUS EXEMESTANE VS. BEVACIZUMAB PLUS PACLITAXEL AND BEVACIZUMAB PLUS CAPECITABINE FOR THE MANAGEMENT OF POSTMENOPAUSAL WOMEN WITH ER+ BREAST CANCER
Kourlaba, G., Rapti, V., Alexopoulos, A., Relakis, J., Koumakis, G., Chatzikou, M., Maniadakis, N., Georgoulias, V.Volume:
25
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdu329.4
Date:
September, 2014
File:
PDF, 62 KB
2014